S.Amdt. 3084

SA 3084. Mrs. MURRAY (for herself and Mr. Justice) submitted an
amendment intended to be proposed by her to the bill S. 2296, to
authorize appropriations for fiscal year 2026 for military activities
of the Department of Defense, for military construction, and for
defense activities of the Department of Energy, to prescribe military
personnel strengths for such fiscal year, and for other purposes; which
was ordered to lie on the table; as follows:

At the end of subtitle C of title VII, add the following:

SEC. 724. EVALUATION OF CERTAIN RESEARCH RELATED TO
MENOPAUSE, PERIMENOPAUSE, OR MID-LIFE WOMEN'S
HEALTH.

(a) In General.--The Secretary of Defense, in coordination
with Secretary of Veterans Affairs, shall evaluate--
(1) the results of completed research related to menopause,
perimenopause, or mid-life women's health among women who are
members of the uniformed services or veterans;
(2) the status of such research that is ongoing;
(3) any gaps in knowledge and research on--
(A) treatments for menopause-related symptoms, including
hormone and non-hormone treatments;
(B) the safety and effectiveness of treatments for
menopause-related symptoms;
(C) the relation of service in the uniformed services to
perimenopause and menopause and the impact of such service on
perimenopause and menopause; and
(D) the impact of perimenopause and menopause on the mental
health of women who are members of the uniformed services or
veterans;

[[Page S4838]]

(4) the availability of and uptake of professional training
resources for covered providers relating to mid-life women's
health with respect to the care, treatment, and management of
perimenopause and menopausal symptoms, and related support
services; and
(5) the availability of and uptake of treatments for women
who are members of the uniformed services or veterans who are
experiencing perimenopause or menopause.
(b) Report; Strategic Plan.--Not later than 180 days after
the date of the enactment of this Act, the Secretary of
Defense and the Secretary of Veterans Affairs shall each
submit to Congress a report containing--
(1) the findings of the evaluation conducted under
subsection (a);
(2) recommendations for improving professional training
resources described in subsection (a)(4) for covered
providers; and
(3) a strategic plan that--
(A) resolves the gaps in knowledge and research identified
in the report; and
(B) identifies topics in need of further research relating
to potential treatments for menopause-related symptoms of
women who are members of the uniformed services or veterans.
(c) Nonduplication and Supplementation of Efforts.--In
carrying out activities under this section, the Secretary of
Defense and the Secretary of Veterans Affairs shall ensure
that such activities minimize duplication and supplement, not
supplant, existing information-sharing efforts of the
Department of Health and Human Services.
(d) Sense of Congress on Additional Research Related to
Menopause, Perimenopause, or Mid-life Women's Health.--It is
the sense of Congress that the Secretary of Defense and the
Secretary of Veterans Affairs should each conduct research
related to menopause, perimenopause, or mid-life health
regarding women who are members of the uniformed services or
veterans.
(e) Definitions.--In this section:
(1) Covered provider.--The term ``covered provider'' means
a health care provider employed by the Department of Defense
or the Department of Veterans Affairs.
(2) Menopause.--The term``menopause'' means the stage of a
woman's life--
(A) when menstrual periods stop permanently and she can no
longer get pregnant; and
(B) that is not a disease state, but a normal part of aging
for women.
(3) Mid-life.--The term``mid-life'' means a life stage
that--
(A) coincides with the menopausal transition in women,
which may be physical or emotional;
(B) encompasses the late reproductive age, which can begin
at approximately 35 years of age, to the late postmenopausal
stages of reproductive aging, which can extend to
approximately 65 years of age; and
(C) often marks the onset of many chronic diseases.
(4) Perimenopause.--The term ``perimenopause'' means the
time during a woman's life when levels of the hormone
estrogen fall unevenly in a woman's body and is also called
the menopausal transition.
(5) Postmenopausal.--The term ``postmenopausal'' means the
stage of a woman's life after a woman has been without a
menstrual period for 12 months that lasts for the rest of a
woman's life and reflects a time when women are at increased
risk for osteoporosis and heart disease.
______